Gentronix Limited Signs First Japanese Contracted Screening Collaboration With Kowa Company
9/5/2012 9:54:22 AM
More...
|
Kowa Company Announces the Efficacy and Safety of a Novel Phosphodiesterase 3 Inhibitor K-134 for the Treatment of Intermittent Claudication in American Heart Association 2011
11/10/2011 7:59:31 AM
More...
|
Kowa Company Announces the Efficacy and Safety of a Novel Rho Kinase Inhibitor (K-115) in the Treatment of Glaucoma in Association for Research in Vision & Ophthalmology 2011
5/10/2011 10:25:47 AM
More...
|
Kowa Company Announces Peretinoin Reduces Recurrence Risk of Hepatocellular Carcinoma after Curative Therapy
9/13/2010 12:49:43 PM
More...
|
Eli Lilly and Company (LLY), Kowa Company and Kowa Pharmaceuticals America Announce Co-Promotion and Licensing Agreement
12/23/2009 8:42:49 AM
More...
|
Kowa Company: Study Demonstrates LIVALO(R) Is an Efficacious Treatment for Achieving Lipid Goals LIVALO Superior to Simvastatin in Reducing LDL-C When Comparing Starting Doses
10/22/2009 11:06:49 AM
More...
|
Kowa Company: LIVALO(R) Demonstrates Sustained, Long-Term Efficacy and Tolerability in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia
9/1/2009 10:57:48 AM
More...
|
Kowa Company Study Demonstrates Efficacy of Pitavastatin in Elderly Patients
6/16/2009 8:38:35 AM
More...
|
Teva Pharmaceutical Industries Limited (TEVA) (JOBS), Kowa Company to Partner in Generic Pharma Company in Japan; New Company Teva-Kowa Pharma Co.
9/24/2008 7:17:33 AM
More...
|
Kowa Company Acquires ProEthic Pharmaceuticals, Inc. New Company to be Called Kowa Pharmaceuticals America
8/4/2008 9:25:00 AM
More...
|
|